Skip to content
OpenCapital
Get started

Emergent Biosolutions EBS Q3 2025 earnings

Reported October 29, 2025 · After market close

Revenue$231.1MBeat by $13.6M
EPS$1.06Beat by $1.18
Revenue estimate$217.5M
EPS estimate-$0.12

Next report

Aug 5, 2026 (In 6 days)
Revenue estimate$177.5M
EPS estimate-$0.09

Financials

Q3 2025

Income statement

See full
Revenue$231.1M-21.3%
Gross profit$145.2M-15.2%
Operating income$76.5M+18.6%
Net income$51.2M-55.4%
EPS (diluted)$0.91-55.8%

Balance sheet

See full
Cash & equivalents$249.2M+59.3%
Total debt$671.0M-0.7%
Total equity$582.5M+14.6%
Total assets$1.5B-1.1%

Cash flow

See full
Operating cash flow--100%
CapEx$3.4M-41.4%
Free cash flow--100%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$470.56M+6.5%
Enterprise value$892.36M-7.2%
P/E6.2×—
P/S0.6×+0.2×

Profitability

See full
Gross margin54.5%+21.0pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.2×-0.2×
Current ratio5.8×+2.9×

Segments

By product

See full
MCM Product sales$142.5M-18.2%
Commercial Product sales$74.9M-21.4%
All other revenue$13.7M—

By segment

See full
MCM Products$142.5M-18.2%

By geography

See full
Canada$18.8M—

Versus estimates

Revenue

Q1 2026$156.1MBeat by $11.1MQ4 2025$148.7MMiss by $68.8M
Q3 2025$231.1MBeat by $13.6M
Q2 2025$140.9MMiss by $62.8MQ1 2025$222.2MBeat by $3.2MQ4 2024$189.3MMiss by $89.7M

Diluted EPS

Q1 2026$0.21Beat by $0.46Q4 2025-$0.43Miss by $0.54
Q3 2025$1.06Beat by $1.18
Q2 2025$0.16Beat by $0.42Q1 2025$0.71Beat by $0.22Q4 2024$0.05Beat by $0.40

Ask the moment Emergent Biosolutions reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Emergent Biosolutions report Q3 2025 earnings?
Emergent Biosolutions (EBS) reported Q3 2025 earnings on October 29, 2025 after market close.
What were Emergent Biosolutions's Q3 2025 revenue and EPS?
Emergent Biosolutions reported revenue of $231.1M and eps of $1.06 for Q3 2025.
Did Emergent Biosolutions beat estimates in Q3 2025?
Revenue beat the consensus estimate of $217.5M by $13.6M. EPS beat the consensus estimate of $-0.12 by $1.18.
How did Emergent Biosolutions's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 21.3% from $293.8M a year earlier and eps declined 22.6% from $1.37.
Where can I find Emergent Biosolutions's Q3 2025 SEC filings?
You can read the 10-Q periodic report (0001367644-25-000202) directly on SEC EDGAR. The filing index links above go to sec.gov.